226 related articles for article (PubMed ID: 29096832)
1. Antioxidant defense system in familial hypercholesterolemia and the effects of lipoprotein apheresis.
Blaha V; Blaha M; Solichová D; Krčmová LK; Lánská M; Havel E; Vyroubal P; Zadák Z; Žák P; Sobotka L
Atheroscler Suppl; 2017 Nov; 30():159-165. PubMed ID: 29096832
[TBL] [Abstract][Full Text] [Related]
2. Effects of LDL-immunoapheresis on plasma concentrations of vitamin E and carotenoids in patients with familial hypercholesterolemia.
Cauza E; Jansen M; Resch U; Dunky A; Derfler K; Winklhofer-Roob BM; Kostner K
J Clin Apher; 2004; 19(4):174-9. PubMed ID: 15597350
[TBL] [Abstract][Full Text] [Related]
3. Small, dense high-density lipoprotein 3 particles exhibit defective antioxidative and anti-inflammatory function in familial hypercholesterolemia: Partial correction by low-density lipoprotein apheresis.
Hussein H; Saheb S; Couturier M; Atassi M; Orsoni A; Carrié A; Therond P; Chantepie S; Robillard P; Bruckert E; Chapman MJ; Kontush A
J Clin Lipidol; 2016; 10(1):124-33. PubMed ID: 26892129
[TBL] [Abstract][Full Text] [Related]
4. Effect of lipoprotein apheresis on oxidative stress and antioxidant status in familial hypercholesterolemic patients.
Kurtoglu E; Ugur A; Sait Gonen M; KiSakol G
Int J Artif Organs; 2003 Nov; 26(11):1039-43. PubMed ID: 14708833
[TBL] [Abstract][Full Text] [Related]
5. The Effect of LDL-Apheresis and Rheohaemapheresis Treatment on Vitamin E.
Solichová D; Bláha M; Aufartová J; Krcmová LK; Plíšek J; Honegrová B; Kasalová E; Lánská M; Urbánek L; Sobotka L
J Nutr Sci Vitaminol (Tokyo); 2015; 61(2):105-12. PubMed ID: 26052140
[TBL] [Abstract][Full Text] [Related]
6. The effect of selective low-density lipoprotein apheresis on plasma lipoperoxides and antioxidant vitamins in familial hypercholesterolemic patients.
Baricchi R; Pizzala R; Cacciavillani G; Rivasi P; Tomasi A
Ther Apher; 1998 Aug; 2(3):218-23. PubMed ID: 10227773
[TBL] [Abstract][Full Text] [Related]
7. Oxidizability of atherogenic low-density lipoprotein subspecies in severe familial hypercholesterolemia: impact of long-term low-density lipoprotein apheresis.
Lepage S; Nigon F; Bonnefont-Rousselot D; Assogba U; Goulinet S; Chancharme L; Delattre J; Bruckert E; Chapman MJ
J Cardiovasc Pharmacol Ther; 2000 Apr; 5(2):87-103. PubMed ID: 11150388
[TBL] [Abstract][Full Text] [Related]
8. Acute effects of LDL-apheresis on cholesterol oxidation products and antioxidants in plasma and lipoproteins of patients with familial hypercholesterolemia.
Linseisen J; Wilhelm M; Hoffmann J; Hailer S; Keller C; Wolfram G
Eur J Med Res; 1999 Oct; 4(10):433-41. PubMed ID: 10527957
[TBL] [Abstract][Full Text] [Related]
9. Decreased susceptibility of low-density lipoproteins to in-vitro oxidation after dextran-sulfate LDL-apheresis treatment.
Leitinger N; Pirich C; Blazek I; Endler G; Sinzinger H
Atherosclerosis; 1996 Oct; 126(2):305-12. PubMed ID: 8902156
[TBL] [Abstract][Full Text] [Related]
10. Changes in serum afamin and vitamin E levels after selective LDL apheresis.
Varga VE; Lőrincz H; Szentpéteri A; Juhász L; Seres I; Paragh G; Balla J; Paragh G; Harangi M
J Clin Apher; 2018 Oct; 33(5):569-575. PubMed ID: 30247793
[TBL] [Abstract][Full Text] [Related]
11. The lipid-lowering effects of lomitapide are unaffected by adjunctive apheresis in patients with homozygous familial hypercholesterolaemia - a post-hoc analysis of a Phase 3, single-arm, open-label trial.
Stefanutti C; Blom DJ; Averna MR; Meagher EA; Theron Hd; Marais AD; Hegele RA; Sirtori CR; Shah PK; Gaudet D; Vigna GB; Sachais BS; Di Giacomo S; du Plessis AM; Bloedon LT; Balser J; Rader DJ; Cuchel M;
Atherosclerosis; 2015 Jun; 240(2):408-14. PubMed ID: 25897792
[TBL] [Abstract][Full Text] [Related]
12. Lipoprotein apheresis.
Moriarty PM; Hemphill L
Cardiol Clin; 2015 May; 33(2):197-208. PubMed ID: 25939293
[TBL] [Abstract][Full Text] [Related]
13. Nonpharmacological lipoprotein apheresis reduces arterial inflammation in familial hypercholesterolemia.
van Wijk DF; Sjouke B; Figueroa A; Emami H; van der Valk FM; MacNabb MH; Hemphill LC; Schulte DM; Koopman MG; Lobatto ME; Verberne HJ; Fayad ZA; Kastelein JJ; Mulder WJ; Hovingh GK; Tawakol A; Stroes ES
J Am Coll Cardiol; 2014 Oct; 64(14):1418-26. PubMed ID: 25277610
[TBL] [Abstract][Full Text] [Related]
14. Long-term therapeutic efficacy of lipoprotein apheresis on circulating oxidative stress parameters--A comparison of two different apheresis techniques.
Kopprasch S; Bornstein SR; Bergmann S; Graessler J; Julius U
Atheroscler Suppl; 2015 May; 18():80-4. PubMed ID: 25936309
[TBL] [Abstract][Full Text] [Related]
15. [H.E.L.P. apheresis and oxidative stress].
Pulawski E; Mellwig KP; Horstkotte D
Z Kardiol; 2003; 92(Suppl 3):III38-41. PubMed ID: 14663600
[TBL] [Abstract][Full Text] [Related]
16. Acute and long-term effects of low-density lipoprotein (LDL)-apheresis on oxidative damage to LDL and reducing capacity of erythrocytes in patients with severe familial hypercholesterolaemia.
Stefanutti C; Di Giacomo S; Vivenzio A; Isacchi GC; Masella R; Caprari P; Varì R; Tarzia A; Mosiello A; Cantafora A
Clin Sci (Lond); 2001 Feb; 100(2):191-8. PubMed ID: 11171288
[TBL] [Abstract][Full Text] [Related]
17. Plasmalogen phospholipids in plasma lipoproteins of normolipidemic donors and patients with hypercholesterolemia treated by LDL apheresis.
Bräutigam C; Engelmann B; Reiss D; Reinhardt U; Thiery J; Richter WO; Brosche T
Atherosclerosis; 1996 Jan; 119(1):77-88. PubMed ID: 8929259
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein apheresis and new therapies for severe familial hypercholesterolemia in adults and children.
Page MM; Bell DA; Hooper AJ; Watts GF; Burnett JR
Best Pract Res Clin Endocrinol Metab; 2014 Jun; 28(3):387-403. PubMed ID: 24840266
[TBL] [Abstract][Full Text] [Related]
19. Review: the oxidant/antioxidant balance during regular low density lipoprotein apheresis.
Schettler V; Methe H; Staschinsky D; Schuff-Werner P; Müller GA; Wieland E
Ther Apher; 1999 Aug; 3(3):219-26. PubMed ID: 10427619
[TBL] [Abstract][Full Text] [Related]
20. [The plasma antioxidant status and trace elements in patients with familial hypercholesterolemia treated with LDL-apheresis].
Delattre J; Lepage S; Jaudon MC; Bruckert E; Assogba U; Bonnefont-Rousselot D
Ann Pharm Fr; 1998; 56(1):18-25. PubMed ID: 9770031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
